Also, ferrocene derivatives have shown to inhibit the growth of NSCLC harboring oncogenic mutant K-Ras via mechanisms that have not been elucidated (Arambula et al, 2016; Larik et al, 2016; Wang et al, 2020). This evidence concerns the gene KRAS and non-small cell lung carcinoma.